P1296: SUPPRESSING SYNTHESIS OF THE LONG ISOFORM OF THE PROLACTIN RECEPTOR IS A TARGETED STRATEGY TO TREAT AUTOIMMUNE B-LYMPHOPROLIFERATIVE DISEASES AND B CELL MALIGNANCIES. (23rd June 2022) - Taghi Khani, A.; Kumar, A.; Radecki, K.; Lee, S. J.; Sanchez Ortiz, A.; Lorenson, M.; Wu, X.; Koff, J.; Forman, S.; Gu, Z.; Walker, A.; Swaminathan, S.